DBTX — Decibel Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP-Penn Entertainment, Roblox, Sonendo
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Heritage Insurance, Mirati
U.S. STOCKS ON THE MOVE-Marqeta, Natgas firms, Bumble
U.S. STOCKS ON THE MOVE-Toast, Axon Enterprise, Decibel Therapeutics
Brief: Regeneron To Acquire Decibel Therapeutics, Strengthening Gene Therapy And Hearing Loss Programs
Decibel Therapeutics surges on $109 million buyout deal
Decibel Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Decibel Therapeutics To Present DB-020 Phase 1b Clinical Trial Data
Brief: Decibel Therapeutics Reports First Quarter 2023 Financial Results And Corporate Update
Brief: Decibel Therapeutics Announces Approval Of Clinical Trial Application To Initiate Clinical Development Of Lead Gene Therapy Candidate, Db-OTO
Decibel Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Decibel Therapeutics gains as hearing loss therapy gets orphan tag in Europe
Brief: Decibel Therapeutics Receives European Orphan Drug Designation For Lead Gene Therapy Candidate
Decibel Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
U.S. STOCKS ON THE MOVE-Jack Henry, Coty, Netflix